ASHLEY DENHOF: Open Payments
NPI 1700410446 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,832 in 108 payments from 21 companies in 2025. Trend: 2023 $1,497 · 2024 $1,267 · 2025 $1,832
Food & beverage: $1,832
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 28 | $396 |
| Novo Nordisk Inc | 10 | $221 |
| Novartis Pharmaceuticals Corporation | 13 | $190 |
| PFIZER INC. | 8 | $162 |
| Alnylam Pharmaceuticals Inc. | 6 | $106 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $104 |
| Amgen Inc. | 5 | $98 |
| Medtronic, Inc. | 1 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 13 | $70 |
Products named: CAMZYOS, Wegovy, LEQVIO, ELIQUIS, VYNDAQEL, ONPATTRO, Kerendia, REPATHA.
Industry payments across MI — which companies pay providers there.
